SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000819050-22-000016
Filing Date
2022-03-15
Accepted
2022-03-15 07:43:41
Documents
68
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bbi-20211231.htm   iXBRL 10-K 1661368
2 EX-4.10 a2021123110kex410.htm EX-4.10 19483
3 EX-21.1 a2021123110kex211.htm EX-21.1 4550
4 EX-23.1 a2021123110kex231.htm EX-23.1 10924
5 EX-31.1 a2021123110kex311.htm EX-31.1 10109
6 EX-31.2 a2021123110kex312.htm EX-31.2 9838
7 EX-32.1 a2021123110kex321.htm EX-32.1 8909
13 bbi-20211231_g1.jpg GRAPHIC 217966
  Complete submission text file 0000819050-22-000016.txt   7006422

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20211231.xsd EX-101.SCH 42296
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20211231_cal.xml EX-101.CAL 47455
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20211231_def.xml EX-101.DEF 230164
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20211231_lab.xml EX-101.LAB 570564
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20211231_pre.xml EX-101.PRE 364935
62 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20211231_htm.xml XML 821661
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21088 | Film No.: 22739141
SIC: 2836 Biological Products, (No Diagnostic Substances)